Treatment of Moderate to Severe Refractory Crohn's Disease

NCT06721962 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohns Disease

Interventions

BIOLOGICAL: TRX103
DRUG: Cyclophosphamide

Sponsor

Tr1X, Inc.